Who
Nancy McKinstry
Director
Company insider
Files Form 4 as: Director, Accenture; Director, Mondelez International; Director, Abbott Laboratories; Director, MortgageIT Holdings.
In numbers
- Trades disclosed
- 103
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $188K
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 13 Jun 2006
- Last trade
- 14 Aug 2026
- Last filed
- 17 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 17 Aug 2026 | ACN AccentureIT Services & Consulting | SEC FORM 4 Code A | —12 at $0.00 | filing |
| 14 Aug 2026filed 17 Aug 2026 | ACN AccentureIT Services & Consulting | SEC FORM 4 Code A | —12 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | MDLZ Mondelez InternationalFood Products | SEC FORM 4 Code A | —3,525 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | MDLZ Mondelez InternationalFood Products | SEC FORM 4 Code A | —3,525 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | ACN AccentureIT Services & Consulting | SEC FORM 4 Code A | —12 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | ACN AccentureIT Services & Consulting | SEC FORM 4 Code A | —12 at $0.00 | filing |
| 24 Apr 2026filed 28 Apr 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —2,286 at $0.00 | filing |
| 24 Apr 2026filed 28 Apr 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,305 at $0.00 | filing |
| 24 Apr 2026filed 28 Apr 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,305 at $0.00 | filing |
| 24 Apr 2026filed 28 Apr 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —2,286 at $0.00 | filing |
| 13 Feb 2026filed 17 Feb 2026 | ACN AccentureIT Services & Consulting | SEC FORM 4 Code A | —7 at $0.00 | filing |
| 13 Feb 2026filed 17 Feb 2026 | ACN AccentureIT Services & Consulting | SEC FORM 4 Code F | $8964 at $224.11 | filing |
| 13 Feb 2026filed 17 Feb 2026 | ACN AccentureIT Services & Consulting | SEC FORM 4 Code A | —7 at $0.00 | filing |
| 13 Feb 2026filed 17 Feb 2026 | ACN AccentureIT Services & Consulting | SEC FORM 4 Code F | $8964 at $224.11 | filing |
| 6 Feb 2026filed 10 Feb 2026 | ACN AccentureIT Services & Consulting | SEC FORM 4 Code F | $94K398 at $236.55 | filing |
| 6 Feb 2026filed 10 Feb 2026 | ACN AccentureIT Services & Consulting | SEC FORM 4 Code F | $94K398 at $236.55 | filing |
| 28 Jan 2026filed 29 Jan 2026 | ACN AccentureIT Services & Consulting | SEC FORM 4 Code A | —1,212 at $0.00 | filing |
| 28 Jan 2026filed 29 Jan 2026 | ACN AccentureIT Services & Consulting | SEC FORM 4 Code A | —1,212 at $0.00 | filing |
| 14 Nov 2025filed 18 Nov 2025 | ACN AccentureIT Services & Consulting | SEC FORM 4 Code A | —6 at $0.00 | filing |
| 15 Aug 2025filed 18 Aug 2025 | ACN AccentureIT Services & Consulting | SEC FORM 4 Code A | $1,2385 at $247.57 | filing |
News
ADP Nominates David W. Kenny and Nancy McKinstry to Board of Directorsprnewswire.com · 24 Sep 2026Abbott Laboratories (NYSE:ABT) Given "Buy" Rating at TD CowenABT · dailypolitical.com · 16 Oct 2026Abbott Laboratories is More than a Dividend Stock. Here's Why.ABT · insidermonkey.com · 11 Oct 2026Barclays Initiates Coverage on Abbott Laboratories (NYSE:ABT)ABT · themarketsdaily.com · 9 Oct 2026
1 headline in the last 90 days name Nancy McKinstry; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.